Ilumira
The purest n.c.a Lu-177
Changing the Future of
Cancer Treatment
Ilumira is a high-performance radioisotope designed to bind with targeting molecules, precisely aiming at tumors and metastases. By delivering radiation directly to cancer cells, it minimizes damage to healthy tissues, offering a more hopeful treatment option for cancer patients.
Unmatched Quality
．99.9% radioisotope purity with exceptional specificity and activity
．More efficient, cost-effective and environmentally friendly due to advanced separation technology.
Reliable Supply
．Manufactured under cGMP-certified processes to ensure quality and stable assurance
．Eliminates dependence on Russian sources and aging nuclear reactors
Fast and Efficient Distribution
．Rapid shipping keeps research and treatments plans on track
．Reduce customs clearance delays with Primo’s streamlined import processes
Regulatory Compliance
．Meets or exceeds European Pharmacopeia standards
．Operates to cGMP as defined by ICH Q7 and FDA 21CFR to ensure regulatory compliance
．Drug Master File ( DMF ) is filed with the U.S. FDA
Contact Us
As an Asia distribution hub based in Taiwan, Primo is committed to providing efficient logistics services, ensuring the rapid delivery of Ilumira to multiple countries across the region. This minimizes transport time and cold chain risks, preserving the product’s integrity and potency.